Children with acute lymphoblastic leukemia (ALL), treated with L-asparaginase are at risk for cerebral thrombosis or hemorrhage because of coagulation protein deficiencies.
coagulation protein deficiencies
L-asparaginase
hemorrhage
L-asparaginase
cerebral thrombosis
L-asparaginase